Thalys Medical Technology Group Corporation

SHSE:603716 Stock Report

Market Cap: CN¥1.5b

Thalys Medical Technology Group Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Thalys Medical Technology Group.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth43.2%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Thalys Medical Technology Group Corporation (SHSE:603716) Shares Fly 26% But Investors Aren't Buying For Growth

Nov 20
Thalys Medical Technology Group Corporation (SHSE:603716) Shares Fly 26% But Investors Aren't Buying For Growth

Thalys Medical Technology Group Corporation (SHSE:603716) Surges 28% Yet Its Low P/S Is No Reason For Excitement

Aug 12
Thalys Medical Technology Group Corporation (SHSE:603716) Surges 28% Yet Its Low P/S Is No Reason For Excitement

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Thalys Medical Technology Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SHSE:603716 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/20241,897-211-827N/A
6/30/20241,971-165-75-39N/A
3/31/20242,047-1412060N/A
12/31/20232,006-15985126N/A
9/30/20232,076-153-2033N/A
6/30/20232,170-154185234N/A
3/31/20232,174-190132184N/A
12/31/20222,309-154-2728N/A
9/30/20222,536-55151159N/A
6/30/20222,552-51-136-132N/A
3/31/20222,662-33-294-239N/A
12/31/20212,600-50-194-134N/A
9/30/20212,59530-1181N/A
6/30/20212,55253-11232N/A
3/31/20212,36188-4778N/A
12/31/20202,12558-11810N/A
9/30/20201,87850-159-41N/A
6/30/20201,76162-5351N/A
3/31/20201,752648102N/A
12/31/20191,831110-394N/A
9/30/20191,699112-111-8N/A
6/30/20191,585102-139-41N/A
3/31/20191,41797-187-89N/A
12/31/20181,31794-182-64N/A
9/30/20181,231110-250-124N/A
6/30/20181,135105N/A-113N/A
3/31/20181,01898N/A-111N/A
12/31/201792194N/A-63N/A
9/30/201778774N/A-28N/A
6/30/201769470N/A-51N/A
3/31/201765273N/A-17N/A
12/31/201662769N/A-17N/A
9/30/201660069N/A22N/A
12/31/201553061N/A46N/A
12/31/201444557N/A30N/A
12/31/201339249N/A33N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 603716's forecast earnings growth is above the savings rate (2.8%).

Earnings vs Market: Insufficient data to determine if 603716's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 603716's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 603716's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 603716's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 603716's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y